BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26838046)

  • 21. Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice.
    Braeuning A; Singh Y; Rignall B; Buchmann A; Hammad S; Othman A; von Recklinghausen I; Godoy P; Hoehme S; Drasdo D; Hengstler JG; Schwarz M
    Histochem Cell Biol; 2010 Nov; 134(5):469-81. PubMed ID: 20886225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
    Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
    Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice.
    Yamamoto Y; Moore R; Goldsworthy TL; Negishi M; Maronpot RR
    Cancer Res; 2004 Oct; 64(20):7197-200. PubMed ID: 15492232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) promotes mouse hepatocarcinogenesis by activating transforming growth factor-β and Wnt/β-catenin signaling pathways.
    Xie XL; Wei M; Kakehashi A; Yamano S; Tajiri M; Wanibuchi H
    Toxicol Sci; 2012 Feb; 125(2):392-400. PubMed ID: 22094457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR.
    Braeuning A; Gavrilov A; Brown S; Wolf CR; Henderson CJ; Schwarz M
    Toxicol Sci; 2014 Aug; 140(2):259-70. PubMed ID: 24863967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver.
    Yamada T; Okuda Y; Kushida M; Sumida K; Takeuchi H; Nagahori H; Fukuda T; Lake BG; Cohen SM; Kawamura S
    Toxicol Sci; 2014 Nov; 142(1):137-57. PubMed ID: 25145657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
    Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
    Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
    Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
    Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
    Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
    Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.
    Loeppen S; Koehle C; Buchmann A; Schwarz M
    Carcinogenesis; 2005 Jan; 26(1):239-48. PubMed ID: 15471898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.
    Waaler J; Machon O; Tumova L; Dinh H; Korinek V; Wilson SR; Paulsen JE; Pedersen NM; Eide TJ; Machonova O; Gradl D; Voronkov A; von Kries JP; Krauss S
    Cancer Res; 2012 Jun; 72(11):2822-32. PubMed ID: 22440753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TMEM9-v-ATPase Activates Wnt/β-Catenin Signaling Via APC Lysosomal Degradation for Liver Regeneration and Tumorigenesis.
    Jung YS; Stratton SA; Lee SH; Kim MJ; Jun S; Zhang J; Zheng B; Cervantes CL; Cha JH; Barton MC; Park JI
    Hepatology; 2021 Feb; 73(2):776-794. PubMed ID: 32380568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of connexin32 and beta-catenin in tumor promotion in mouse liver.
    Schwarz M; Wanke I; Wulbrand U; Moennikes O; Buchmann A
    Toxicol Pathol; 2003; 31(1):99-102. PubMed ID: 12597453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of Wnt/beta-catenin signaling transduction pathway in rat hepatocarcinogenesis].
    Wang QM; Li X; Jia LQ; Yang KM; Zhou HY; Yang HJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):454-7. PubMed ID: 16806007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse.
    Matsumoto K; Huang J; Viswakarma N; Bai L; Jia Y; Zhu YT; Yang G; Borensztajn J; Rao MS; Zhu YJ; Reddy JK
    Carcinogenesis; 2010 Feb; 31(2):318-25. PubMed ID: 20007298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis.
    Phillips JM; Yamamoto Y; Negishi M; Maronpot RR; Goodman JI
    Toxicol Sci; 2007 Mar; 96(1):72-82. PubMed ID: 17172636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.